Market capitalization | $644.39m |
Enterprise Value | $642.74m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 3.39 |
P/S ratio (TTM) P/S ratio | 3.40 |
P/B ratio (TTM) P/B ratio | 1.74 |
Revenue growth (TTM) Revenue growth | 33.47% |
Revenue (TTM) Revenue | $189.67m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
6 Analysts have issued a OrthoPediatrics Corp. forecast:
6 Analysts have issued a OrthoPediatrics Corp. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 190 190 |
33%
33%
|
|
Gross Profit | 119 119 |
33%
33%
|
|
EBITDA | -8.46 -8.46 |
15%
15%
|
EBIT (Operating Income) EBIT | -29 -29 |
12%
12%
|
Net Profit | -28 -28 |
29%
29%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
Head office | United States |
CEO | David Bailey |
Employees | 247 |
Founded | 2006 |
Website | www.orthopediatrics.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.